Published in Med Decis Making on September 16, 2015
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ (1999) 3.82
Handling uncertainty in cost-effectiveness models. Pharmacoeconomics (2000) 3.37
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA (2003) 3.25
Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol (2007) 2.49
Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis. Med Decis Making (2007) 2.46
Expected value of sample information calculations in medical decision modeling. Med Decis Making (2004) 2.04
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Ann Intern Med (2012) 1.96
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making (2012) 1.81
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making (2012) 1.61
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol (2002) 1.26
When is evidence sufficient? Health Aff (Millwood) (2005) 1.12
Estimating the expected value of partial perfect information: a review of methods. Eur J Health Econ (2007) 1.01
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One (2011) 0.98
Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches. Pharmacoeconomics (2012) 0.92
Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis. Med Decis Making (2004) 0.92
Handling input correlations in pharmacoeconomic models. Value Health (2012) 0.88
The effect of neglecting correlations when propagating uncertainty and estimating the population distribution of risk. Risk Anal (1992) 0.87
Correlations in uncertainty analysis for medical decision making: an application to heart-valve replacement. Med Decis Making (1999) 0.85
Linear regression metamodeling as a tool to summarize and present simulation model results. Med Decis Making (2013) 0.82
Modeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India. Med Decis Making (2014) 0.81
Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis. Med Decis Making (2006) 0.78
Correlations between parameters in risk models: estimation and propagation of uncertainty by Markov Chain Monte Carlo. Risk Anal (2003) 0.77